Announcement
23 Oct 2026
: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology
Learn More

Harnessing the Power of Proteomic

31 January 2024
Specialized Medical Fields

About the Speakers

  • Albarah El Khani
    Chief Operating Officer, Integrated Health Solutions, M42
  • Dr. Sara Suliman
    Consultant Endocrinologist and Diabetologist for Imperial College London
  • Dr. Tiago Magalhaes
    Vice President Bioinformatics, M42​
  • Dr. Shalini Behl
    R&D Scientist, Omics Centre of Excellence for M42
  • Dr. Nicolas Sirotin
    Former Chair, Preventative Medicine, and Consultant International Medicine for Cleveland Clinic Abu Dhabi

    Watch Next